ArticleAddiction science & clinical practice2025
Tracking functional recovery in a community-based substance use disorder program: a five-year descriptive evaluation using the brief addiction monitor.
Article in Addiction science & clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAccessible, evidence-based treatment for substance use disorders (SUDs) remain a public health challenge due to complex clinical and social needs and barriers to long-term engagement. This study describes a five-year evaluation of a low-barrier, outpatient SUD treatment program implemented by the Health Care District of Palm Beach County, Florida, focusing on trends in functional recovery using the Brief Addiction Monitor (BAM) functional assessment.
methodsBetween February 2018 to March 2023, participants with substance use disorders received care through a Federally Qualified Healthcare Center (FQHC) based integrated model offering medication for opioid use disorder, other Medication assisted treatment, behavioral health services, medical , psychiatric, peer services, and care coordination. The BAM was administered at baseline and approximately every three months to assess substance use, risk, and protective factors. Data were analyzed per assessment to reflect variability in patient engagement and follow-up.
resultsA total of 2,425 patients completed 5,277 BAM assessments. Among those with repeated assessments (n = 982), the average substance use score declined from 5.19 to 3.45, while the risk score dropped from 14.61 to 11.01. Protective scores increased from 10.65 to 12.40. Reported opiate use decreased from 26.1% at baseline to 17.3% at follow-up. Self-reported overdose history declined from 38.6% to 17.5% (added in 2021). Patient satisfaction improved, with “extremely satisfied” responses rising from 21.6% to 36.5%.
conclusionsThis descriptive evaluation highlights the potential of low-threshold, integrated care models to support recovery-oriented outcomes in real-world settings. Routine use of tools like the BAM enabled multidimensional monitoring of progress despite challenges with retention and data completeness. Findings underscore the importance of flexible, patient-centered approaches to managing the chronic nature of SUD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.